A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015

Clinical trial NCT05022771 · COMPLETED

Trial details

NCT number: NCT05022771
Sponsor: Pulmongene Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2021-10-14
Primary completion: 2022-08-18
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.